Paul Tan1,2,3, Carolane Blais2, Thi M-D Nguyen4, Peter W Schiller4,5, Jolanta Gutkowska1,6, Julie L Lavoie1,3,7. 1. Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM). 2. Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Québec, Canada. 3. Montreal Diabetes Research Center, Montréal, Québec, Canada. 4. Institut de Recherches Cliniques de Montréal, Montréal, Québec, Canada. 5. Department of Pharmacology, Université de Montréal, Montréal, Québec, Canada. 6. Department of Medicine, Université de Montréal, Montréal, Québec, Canada. 7. Department of Kinesiology, Université de Montréal, Montréal, Québec, Canada.
Abstract
OBJECTIVE: Administration of the handle region peptide (HRP), a (pro)renin receptor blocker, decreases body weight gain and visceral adipose tissue (VAT) in high-fat/high-carbohydrate (HF/HC) diet-fed mice. The objective of this study was to elucidate potential mechanisms implicated in these observations. METHODS: Mice were given a normal or a HF/HC diet along with saline or HRP for 10 weeks. RESULTS: In HF/HC-fed mice, HRP increased the expression of several enzymes implicated in lipogenesis and lipolysis in subcutaneous fat (SCF) while the expression of the enzyme implicated in the last step of lipogenesis decreased in VAT. A reduction was also observed in circulating free fatty acids in these animals which was accompanied by normalized adipocyte size in VAT and increased adipocyte size in SCF. ''Beiging'' is the evolution of a white adipose tissue toward a brown-like phenotype characterized by an increased mitochondrial density and small lipid droplets. HRP increased the expression of' "beiging" markers in SCF of HF/HC diet-fed mice. CONCLUSIONS: HRP treatment may favor healthy fat storage in SCF by activating a triglyceride/free fatty acid cycling and "beiging," which could explain the body weight and fat mass reduction.
OBJECTIVE: Administration of the handle region peptide (HRP), a (pro)renin receptor blocker, decreases body weight gain and visceral adipose tissue (VAT) in high-fat/high-carbohydrate (HF/HC) diet-fed mice. The objective of this study was to elucidate potential mechanisms implicated in these observations. METHODS:Mice were given a normal or a HF/HC diet along with saline or HRP for 10 weeks. RESULTS: In HF/HC-fed mice, HRP increased the expression of several enzymes implicated in lipogenesis and lipolysis in subcutaneous fat (SCF) while the expression of the enzyme implicated in the last step of lipogenesis decreased in VAT. A reduction was also observed in circulating free fatty acids in these animals which was accompanied by normalized adipocyte size in VAT and increased adipocyte size in SCF. ''Beiging'' is the evolution of a white adipose tissue toward a brown-like phenotype characterized by an increased mitochondrial density and small lipid droplets. HRP increased the expression of' "beiging" markers in SCF of HF/HC diet-fed mice. CONCLUSIONS: HRP treatment may favor healthy fat storage in SCF by activating a triglyceride/free fatty acid cycling and "beiging," which could explain the body weight and fat mass reduction.
Authors: Ralph M Peterson; Larry Beeson; Eloy Shulz; Anthony Firek; Marino De Leon; Hector Balcazar; Serena Tonstad; Zaida R Cordero-Macintyre Journal: Int J Body Compos Res Date: 2010
Authors: Jan H Schefe; Mario Menk; Jana Reinemund; Karin Effertz; Robin M Hobbs; Pier Paolo Pandolfi; Patricia Ruiz; Thomas Unger; Heiko Funke-Kaiser Journal: Circ Res Date: 2006-11-02 Impact factor: 17.367
Authors: F Massiéra; M Bloch-Faure; D Ceiler; K Murakami; A Fukamizu; J M Gasc; A Quignard-Boulange; R Negrel; G Ailhaud; J Seydoux; P Meneton; M Teboul Journal: FASEB J Date: 2001-10-15 Impact factor: 5.191
Authors: Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi Journal: Physiol Rev Date: 2018-07-01 Impact factor: 37.312
Authors: Eva Gatineau; Gertrude Arthur; Audrey Poupeau; Kellea Nichols; Brett T Spear; Nathan R Shelman; Gregory A Graf; Ryan E Temel; Frédérique B Yiannikouris Journal: Am J Physiol Endocrinol Metab Date: 2021-01-18 Impact factor: 4.310